Skip to Main Content

Paper Details

AXL activates YAP through the EGFR-LATS1/2 axis and confers resistance to EGFR-targeted drugs in head and neck squamous cell carcinoma.
Oncogene
3
2023
Author NameAffiliation
Jorge Silvio GutkindMoores Cancer Center, University of California
Jorge Silvio GutkindUniversity of California
  • 1 - 2

Datasets

Release 1.2